In response to demand from surgeons for faster turnaround times and more precise design benefits, MedCAD announced that all metal products including AccuPlate reconstruction plates for the mandible and AccuShape Ti cranioplasty products will now be fully converted to 3D titanium printing technology only. MedCAD’s newly FDA-cleared AccuStride product line for foot and ankle will also feature 3-D printed titanium.
All PEEK products, including AccuShape PEEK Cranial Implants, will continue to be manufactured using traditional CNC milling technology.
“MedCAD continues to invest in and expand 3D titanium printing capabilities, enabling us to commit to faster delivery times and better design features for surgeons for high-demand implants,” said Nancy Hairston, CEO and president of MedCAD. “These improved turnaround times for each patient-specific plate can quickly provide surgeons with bespoke, creative reconstruction options within timeframes that were previously unavailable.”
In response to demand from surgeons for faster turnaround times and more precise design benefits, MedCAD announced that all metal products including AccuPlate reconstruction plates for the mandible and AccuShape Ti cranioplasty products will now be fully converted to 3D titanium printing technology only. MedCAD’s newly FDA-cleared AccuStride...
In response to demand from surgeons for faster turnaround times and more precise design benefits, MedCAD announced that all metal products including AccuPlate reconstruction plates for the mandible and AccuShape Ti cranioplasty products will now be fully converted to 3D titanium printing technology only. MedCAD’s newly FDA-cleared AccuStride product line for foot and ankle will also feature 3-D printed titanium.
All PEEK products, including AccuShape PEEK Cranial Implants, will continue to be manufactured using traditional CNC milling technology.
“MedCAD continues to invest in and expand 3D titanium printing capabilities, enabling us to commit to faster delivery times and better design features for surgeons for high-demand implants,” said Nancy Hairston, CEO and president of MedCAD. “These improved turnaround times for each patient-specific plate can quickly provide surgeons with bespoke, creative reconstruction options within timeframes that were previously unavailable.”
Copy to clipboard 
